Evidence map›Paper›PMID 36636423›Full record

ArticleTranslational lung cancer research2022

The clinico-pathological characteristics of surgically treated young women with NSCLC.

Anna Trojnar, Joanna Domagała-Kulawik, Anna Sienkiewicz-Ulita, Marcin Zbytniewski, Grzegorz M Gryszko, Marcin M Cackowski, Michał Dziedzic, Katarzyna Woźnica, Tadeusz M Orłowski, Dariusz A Dziedzic

Abstract read
In one paragraph

Article in Translational lung cancer research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Inherited genetic risk factors in young-onset lung cancer.medRxiv : the preprint server for health sciences · 2026
    Article
  2. Multi-omics profiling revealsTranslational lung cancer research · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Anna TrojnarDepartment of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, Warsaw, Poland.
Joanna Domagała-KulawikInstitute of Clinical Sciences, Maria Curie-Skłodowska Medical Academy, Warsaw, Poland.
Anna Sienkiewicz-UlitaDepartment of Thoracic Surgery, National Research Institute of Chest Diseases, Warsaw, Poland.
Marcin ZbytniewskiDepartment of Thoracic Surgery, National Research Institute of Chest Diseases, Warsaw, Poland.
Grzegorz M GryszkoDepartment of Thoracic Surgery, National Research Institute of Chest Diseases, Warsaw, Poland.
Marcin M CackowskiDepartment of Thoracic Surgery, National Research Institute of Chest Diseases, Warsaw, Poland.
Michał DziedzicFaculty of Medicine, Medical University of Gdansk, Gdansk, Poland.
Katarzyna WoźnicaFaculty of Mathematics and Information Science, Warsaw University of Technology, Warsaw, Poland.
Tadeusz M OrłowskiDepartment of Thoracic Surgery, National Research Institute of Chest Diseases, Warsaw, Poland.
Dariusz A DziedzicDepartment of Thoracic Surgery, National Research Institute of Chest Diseases, Warsaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Non-small cell lung cancer diagnosed in young patients is rare. Younger patients with lung cancer are mostly female and have a more advanced stage at initial diagnosis. To our knowledge, no studies have compared single-surgical treatment in different age groups among women. Our study aimed to elucidate the clinicopathological characteristics and the best strategies for surgically treating young women with non-small-cell lung cancer. Methods: The data were collected retrospectively from the Polish Lung Cancer Study Group database. Women who were surgically treated for non-small-cell lung cancer between 2007 and 2020 were included in the study. The participants (n=11,460) were divided into two subgroups: aged ≤55 and >55 years. Results: Statistically significant differences were found for grades IB, IIA, IIIA, and IIIB (22.8% Conclusions: Younger women treated surgically were characterized by a lower percentage of comorbidities, were treated in a more advanced stage of the disease and had a lower percentage of postoperative complications, which, however, did not affect the hospitalization time. Despite the more advanced stage of the disease, survival in selected stages was much better than in the group of older women.

Indexed as

lung cancer survivalNon-small cell lung cancersurgical treatmentwomen

Identifiers

PMID36636423
PMCPMC9830258

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.